This roundup of what pharma and healthcare bodies are doing in the mobile space includes iPhone and Android apps from Pfizer and National Institute for Health Research (NIHR), and FDA approvals for MIM's diagnostic app and Sanofi's diabetes monitoring system

The FDA has cleared MIM Software's mobile app for diagnostic X-ray and ultrasound viewing. Radiation oncologists can use medical imaging software firm's Mobile MIM iPhone app (pictured above) to review dose volume histograms, isodose curves, contours, and images for treatment plans – actions commonly restricted to a limited number of dedicated workstations.

Pfizer has funded an Android app produced by the US National Kidney Foundation. The Manage CVD Risk in Reduced GFR app aims to help medical professionals reduce risk factors for cardiovascular disease (CVD). Its functions include an interactive algorithm to quickly identify high-risk patients and apply evidence-based strategies to assess and treat them.

The UK's NIHR has launched an iPhone app that allows pharma, clinicians and patients to access information about clinical trials. The clinical trials gateway app – an Android version of which is coming soon - includes a portfolio of clinical trials running in the UK that can be filtered in a number of ways, including by health condition, location and study sponsor. It also allows direct contact with the trial team for those that want to find out more about a specific study. The NIHR also plans to update the clinical trials gateway website in the spring, as part of the government's Strategy for UK Life Sciences.

Sanofi's iBGStar has become the first FDA-cleared blood glucose monitoring system that directly connects to Apple's iPhone and iPod touch. Developed in partnership with AgaMatrix, iBGStar works with the iBGStar Diabetes Manager App (iBGStar DMA), allowing people with diabetes to monitor their blood glucose, analyse and track their data, and share their readings with healthcare professionals or caregivers. The device can also be used separately from an iPhone or iPod Touch and is already available in Germany, France, Switzerland, the Netherlands and Italy.

A new NHS Android app to help children and young people self-manage their asthma has been launched. My Asthma Log was developed by North East London, North Central London and Essex Health Innovation and Education Cluster (NECLES HIEC) in partnership of Asthma UK, Queen Mary University London and Solar Software. It allows patients to construct an individual asthma plan, log appointments and asthma attacks, and links to Asthma UK's Facebook and Twitter accounts.

(If you can't see the above video demonstration of the My Asthma Log app click here.)

Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more